Sort by
Keyphrases
Voriconazole
100%
Fusarium Species
100%
Amphotericin B
100%
In Vitro Resistance
100%
Antifungal Susceptibility
100%
European Committee on Antimicrobial Susceptibility Testing (EUCAST)
100%
Posaconazole
40%
Susceptibility Testing
40%
Fusarium
20%
Fusarium Solani
20%
Immunocompromised Patients
20%
In Vitro Activity
20%
Antifungal Therapy
20%
Past Exposure
20%
Itraconazole
20%
Species Differences
20%
Local Infection
20%
Treatment Failure
20%
MIC Values
20%
Reference Strain
20%
High Mortality Rate
20%
Disseminated Infection
20%
Invasive Infection
20%
Triazole Antifungal Agents
20%
Late Diagnosis
20%
Susceptibility Pattern
20%
Strain-specific Differences
20%
Fungal Biodiversity
20%
Fusarium Strains
20%
Resistant Profile
20%
Fusarium Petroliphilum
20%
Medicine and Dentistry
In Vitro
100%
Voriconazole
100%
Amphotericin B
100%
Antifungal Susceptibility
100%
Infection
60%
Posaconazole
40%
Mortality Rate
20%
Biodiversity
20%
Antifungal Agent
20%
Immunocompromised Patient
20%
Antifungal Therapy
20%
Itraconazole
20%
Triazole
20%
Immunology and Microbiology
Antifungal Susceptibility
100%
Fusarium
100%
In Vitro
100%
Infection
75%
Susceptibility
75%
Minimum Inhibitory Concentration
50%
Immunocompromised Patient
25%
Mortality Rate
25%
Biodiversity
25%
Pharmacology, Toxicology and Pharmaceutical Science
Amphotericin B
100%
Voriconazole
100%
Fusarium
100%
Infection
60%
Posaconazole
40%
Antifungal Therapy
20%
Itraconazole
20%
Antifungal Agent
20%
Mortality Rate
20%
Immunocompromised Patient
20%
Triazole
20%